Defects of CTLA-4 Are Associated with Regulatory T Cells in Myasthenia Gravis Implicated by Intravenous Immunoglobulin Therapy

• Main Authors: Wenhua Xu (Author), Mingshan Ren (Author), Swagata Ghosh (Author), Kai Qian (Author), Zhaofeng Luo (Author), Aimei Zhang (Author), Cuiping Zhang (Author), Jiajun Cui (Author)
• Formato: Livro
• Publicado em: Hindawi Limited, 2020-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Myasthenia gravis (MG) is a CD4+ T cell-dependent autoimmune disease resulting from aberrant immune response mediated by circulating autoantibodies at the neuromuscular junction. Intravenous immunoglobulin (IVIg) is an expensive and commonly used immunotherapeutic approach to treat patients with MG....